Why you should attend this masterclass
This two-day masterclass will provide you an extensive review of the rationale for Focal Therapy (FT) and the modalities of patient selection. Gain further knowledge and benefit from new FT techniques, modalities of treatment, tools, and development of new energies.
Examine pre-recorded videos and demonstrations, and participate in hands-on training sessions so you can combine theory with practical know-how. Explore its applicability to customise patient treatments according to cancer characteristics.Download programme
Meet the faculty
Check your eligibility
Selection criteria when applying for this masterclass:
The number of representatives per country is a factor in the selection.
To offer equal opportunitiy to participate in this masterclass, the number of representatives per country will be limited.
An EAU membership is mandatory.
Not a member yet? You can sign up here.
Application is on a first-come, first served basis.
To guarantee optimal learning, each masterclass will accommodate a maximum of 40 participants.
What others say about this masterclass
Dr. Dmitry Enikeev (RU):
“My overall impression is positive. The information offered was easy to understand and accessible. I especially liked the multidisciplinary approach when the MRI specialist and the morphologists shared their views. The cordial vibe of the masterclass encouraged good, open communication. To future participants – novice and experienced surgeons – I say to them, this masterclass is definitely worth their time!”
Dr. Cristina Redondo (ES):
“Focal therapy is the future in the treatment of PCa. Technological advances and multidisciplinary interaction between urologists, radiologists and pathologists will allow better understanding of patients’ needs, personalisation and optimisation of treatments. The masterclass provided a good review of the novelties in FT through discussions of various concepts and criteria exchange among experts. As a result, the masterclass became an exemplary learning tool for participants.”
Dr. Matteo Manfredi (IT):
“I highly recommend attending this masterclass. I had big expectations from the start and I can honestly say, all of them were met. I appreciate the comprehensive lectures on FT management and the collaboration among urologists, pathologists, and radiologists. The live surgeries were impressive and helpful to urologists like me who don’t practice it yet in their hospitals. To personalise FT à la carte, experts at the masterclass reported a novel concept: selection of an energy modality based on its limitations, complication profile and intraprostatic cancer location.”
Dr. Amir Arbab (IR):
“The main highlight of the masterclass was the optimisation of PCa treatment while reducing major complications. The delivery of contemporary FT updates, overall learning atmosphere, and the programme as a whole were excellent.